Developing the next generation of cis-targeting macrophage-T cell cancer immunotherapies

Project Information

MiTE

Grant agreement ID: 101123436

DOI

10.3030/101123436

Project closed

EC signature date 23 May 2023

Start date 1 June 2023

End date 31 May 2025

Funded under

• European Research Council (ERC)

Total cost

No data

EU contribution

€ 150 000,00

Coordinated by

WEIZMANN INSTITUTE OF SCIENCE
Israel

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

ZEB2 is a master switch controlling the tumor-associated macrophage program

Author(s): Fadi Sheban, Truong San Phan, Ken Xie, Florian Ingelfinger, Chamutal Gur, Yuval Shapir Itai, Ronnie Blecher-Gonen, Chunsong Yu, Roberto Avellino, Paulina Chalan, Kiara Freitag, Ido Yofe, Vladimir Yutkin, Pierre Boyeau, Can Ergen, Justin Hong, Kfir Mazuz, Yuxiao Liu, Kangming Chen, Rony Dahan, Marcin Kortylewski, Nir Yosef, Assaf Weiner, Ido Amit
Published in: Cancer Cell, Issue 43, 2025, ISSN 1535-6108
Publisher: Elsevier BV
DOI: 10.1016/J.CCELL.2025.03.021